Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO
PUBLIC · GYREOct 22, 2026
Position
Chief Financial Officer
Company
Gyre Therapeutics
Thomas Eastling
San DiegoManufacturingBiotechnologyHealthcareHealth CareTherapeuticsBiopharma
Description
On October 16, 2026, Gyre Therapeutics, Inc. announced the appointment of Ying Luo, Ph.D., as Chief Executive Officer and Thomas Eastling as Chief Financial Officer. Both executives will continue to serve in their respective roles under newly established employment agreements
Who to call at Gyre Therapeutics, and when
A new leader at Gyre Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Gyre Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Gyre Therapeutics, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Gyre Therapeutics
Location
12770 High Bluff Drive
San Diego, California, United States
About
Gyre Therapeutics is an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic diseases. The company focuses on developing treatments for inflammatory diseases and cancers. Gyre aims to leverage its capabilities for manufacturing and commercialization.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gyre Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
San DiegoManufacturingBiotechnologyHealthcareHealth CareTherapeuticsBiopharma